260 results on '"Cosentini, Deborah"'
Search Results
2. The Evolving Treatment Landscape of Medullary Thyroid Cancer
3. Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy
4. Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients
5. Genetics and Molecular Biology of Adrenocortical Carcinoma
6. Integrated Approach in Locally Advanced, Oligometastatic or Recurrent Adrenocortical Carcinoma
7. Epidemiology, Presentation, Staging, and Prognostic Factors in Adrenocortical Carcinoma
8. Medical Treatment of Malignant Pheochromocytoma
9. Medical Treatment in Advanced Adrenocortical Carcinoma
10. Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma
11. Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma
12. Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis
13. Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
14. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
15. Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
16. Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors
17. Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study
18. Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen
19. Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study
20. Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study
21. Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical practice
22. Cancer of the Adrenal Gland
23. Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report.
24. Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies.
25. The Value of Local Therapies in Advanced Adrenocortical Carcinoma
26. Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy
27. Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?
28. THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment
29. THU616 Analysis Of Germline Mutations In Patients With Sporadic Adrenocortical Carcinoma
30. Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy
31. Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures
32. Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021
33. Cancer of the Adrenal Gland
34. Preclinical and clinical evidence of progesterone/megestrol acetate activity in metastatic adrenocortical carcinoma
35. Correction: Sigala et al. A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma. Cells 2022, 11, 1439
36. Real-world use of multigene signatures in early breast cancer: differences to clinical trials
37. Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status
38. Antineoplastic activity of artemisinin in adrenocortical carcinoma
39. In vitro antitumor activity of progesterone in human adrenocortical carcinoma
40. Analysis of germline mutations in patients with non-syndromic adrenocortical carcinoma
41. Assessment of dxa derived bone geometry parameters in early breast cancer patients: a cross-sectional study
42. Prolonged exposure to target mitotane concentrations is associated with better recurrence-free survival in patients with adrenocortical carcinoma on adjuvant treatment
43. Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines
44. Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma
45. Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group
46. Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report
47. Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models
48. Is it time to tailor treatments in androgen receptor positive salivary gland cancers?
49. Preclinical evidence of progesterone as a new pharmacological strategy in human adrenocortical carcinoma cell lines
50. Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.